Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 1
2003 1
2010 3
2011 3
2012 2
2013 6
2014 3
2015 4
2016 1
2018 2
2020 1
2021 2
2022 5
2023 4
2024 7
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean otto (36,979 results)?
Persistent transmission of onchocerciasis in Kwanware-Ottou focus in Wenchi health district, Ghana.
Nditanchou R, Agyemang D, Dixon R, D'Souza S, Selby R, Opare J, Tettevi EJ, Asiedu MD, Idun B, Chailloux A, Schmidt E, Hamill L, Senyonjo L, Osei-Atweneboana MY. Nditanchou R, et al. BMC Infect Dis. 2024 Oct 14;24(1):1156. doi: 10.1186/s12879-024-10071-2. BMC Infect Dis. 2024. PMID: 39402497 Free PMC article.
Infection in blackflies was found only in Kwanware and Ottou, with infectivity rates of 5.9 (per 1000) and 6.7, respectively. (vi) The mf prevalence in Ottou and Kwanware, respectively, was 40.0% and 30.0% among adults aged 20 years, and the anti-(Onchocerca volvulu …
Infection in blackflies was found only in Kwanware and Ottou, with infectivity rates of 5.9 (per 1000) and 6.7, respectively. (vi) Th …
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21.
Fabeni L, Armenia D, Abbate I, Gagliardini R, Mazzotta V, Bertoli A, Gennari W, Forbici F, Berno G, Piermatteo L, Borghi V, Pinnetti C, Vergori A, Mondi A, Parruti G, Di Sora F, Iannetta M, Lichtner M, Latini A, Mussini C, Sarmati L, Perno CF, Girardi E, Antinori A, Ceccherini-Silberstein F, Maggi F, Santoro MM; Italian HIV Drug Resistance Group. Fabeni L, et al. J Antimicrob Chemother. 2024 Sep 3;79(9):2152-2162. doi: 10.1093/jac/dkae189. J Antimicrob Chemother. 2024. PMID: 39028674 Free PMC article.
Anti-hepatitis C antibody carriage and risk of liver impairment in rural-Cameroon: adapting the control of hepatocellular carcinoma for resource-limited settings.
Kamga Wouambo R, Panka Tchinda G, Kagoue Simeni LA, Djouela Djoulako PD, Yateu Wouambo CI, Tamko Mella GF, Tchoumi Leuwat EP, Bello D, Fokam J. Kamga Wouambo R, et al. BMC Infect Dis. 2023 Dec 13;23(1):875. doi: 10.1186/s12879-023-08880-y. BMC Infect Dis. 2023. PMID: 38093205 Free PMC article.
METHODS: A facility-based observational study was conducted from July-August 2021 among individuals attending the "St Monique" Health Center at Ottou, a rural community of Yaounde,Cameroon. Following a consecutive sampling, consenting individuals were tested for anti-HCV a …
METHODS: A facility-based observational study was conducted from July-August 2021 among individuals attending the "St Monique" Health Center …
Switching to bictegravir/emtricitabine/tenofovir alafenamide from efavirenz/emtricitabine/tenofovir disoproxil in virologically suppressed people with HIV: findings from a non-randomized clinical trial (EBONY study).
Gagliardini R, Camici M, Lanini S, Bellagamba R, Ottou S, Plazzi MM, Vergori A, Mazzotta V, Mondi A, Fusto M, Paulicelli J, Tempestilli M, Pinnetti C, Grilli E, Mastrorosa I, De Zottis F, Duca GD, Antinori A. Gagliardini R, et al. Int J Infect Dis. 2025 Sep;158:107961. doi: 10.1016/j.ijid.2025.107961. Epub 2025 Jun 18. Int J Infect Dis. 2025. PMID: 40541768 Free article.
Impact of switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate to bictegravir/emtricitabine/tenofovir alafenamide on psychiatric symptoms and neurocognition.
Vergori A, Del Duca G, Lorenzini P, Brita AC, Mastrorosa I, Fusto M, Camici M, Ottou S, Gagliardini R, Paulicelli J, De Zottis F, Grilli E, Esvan R, Plazzi MM, Mazzotta V, Bellagamba R, Antinori A, Pinnetti C. Vergori A, et al. AIDS. 2025 Mar 1;39(3):270-275. doi: 10.1097/QAD.0000000000004043. Epub 2024 Oct 24. AIDS. 2025. PMID: 39453875 Free PMC article.
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV.
Vergori A, Cozzi Lepri A, Cicalini S, Matusali G, Bordoni V, Lanini S, Meschi S, Iannazzo R, Mazzotta V, Colavita F, Mastrorosa I, Cimini E, Mariotti D, De Pascale L, Marani A, Gallì P, Garbuglia A, Castilletti C, Puro V, Agrati C, Girardi E, Vaia F, Antinori A; HIV-VAC study group. Vergori A, et al. Nat Commun. 2022 Aug 22;13(1):4922. doi: 10.1038/s41467-022-32263-7. Nat Commun. 2022. PMID: 35995780 Free PMC article.
Telemedicine During COVID-19 Pandemic: Lesson Learned from the Lazio Region Infectious Diseases and Emergency Department Network.
Maffongelli G, Bevilacqua N, Vita S, Bartoli TA, Corpolongo A, Benvenuto D, Chiriaco T, Spiga G, Ribaldi S, Zirretta V, Ippolito G, Lauria FN, Vaia F, Nicastri E; COVID Group of the Lazio Region; Bed Manager Group at INMI Spallanzani. Maffongelli G, et al. J Med Syst. 2022 Dec 7;46(12):105. doi: 10.1007/s10916-022-01887-z. J Med Syst. 2022. PMID: 36473993 Free PMC article.
Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022.
Antinori A, Mazzotta V, Vita S, Carletti F, Tacconi D, Lapini LE, D'Abramo A, Cicalini S, Lapa D, Pittalis S, Puro V, Rivano Capparuccia M, Giombini E, Gruber CEM, Garbuglia AR, Marani A, Vairo F, Girardi E, Vaia F, Nicastri E; INMI Monkeypox Group. Antinori A, et al. Euro Surveill. 2022 Jun;27(22):2200421. doi: 10.2807/1560-7917.ES.2022.27.22.2200421. Euro Surveill. 2022. PMID: 35656836 Free PMC article.
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count.
Antinori A, Cicalini S, Meschi S, Bordoni V, Lorenzini P, Vergori A, Lanini S, De Pascale L, Matusali G, Mariotti D, Cozzi Lepri A, Gallì P, Pinnetti C, Gagliardini R, Mazzotta V, Mastrorosa I, Grisetti S, Colavita F, Cimini E, Grilli E, Bellagamba R, Lapa D, Sacchi A, Marani A, Cerini C, Candela C, Fusto M, Puro V, Castilletti C, Agrati C, Girardi E, Vaia F; HIV-VAC Study Group. Antinori A, et al. Clin Infect Dis. 2022 Aug 24;75(1):e552-e563. doi: 10.1093/cid/ciac238. Clin Infect Dis. 2022. PMID: 35366316 Free PMC article.
44 results